Brief: Oncorus Announces Exclusive Licensing Agreement With Gaeta Therapeutics Ltd

Oncorus

11/11/2021 12:01

Nov 11 (Reuters) - Oncorus Inc  ONCR.O :
    * ONCORUS ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH GAETA
THERAPEUTICS LTD. FOR USE OF LOCALLY DELIVERED INTERLEUKIN-12
(IL-12) VIA ONCOLYTIC VIRAL EXPRESSION IN COMBINATION WITH
IMMUNE CHECKPOINT INHIBITORS
    * ONCORUS INC - GAETA WILL RECEIVE PAYMENT OF $0.2M AND IS
ELIGIBLE TO RECEIVE UP TO $7.5M IN POTENTIAL CLINICAL AND
REGULATORY MILESTONE PAYMENTS

Source text for Eikon:  ID:nGNXbLlCFC 
Further company coverage:  ONCR.O 

 ((Reuters.Briefs@thomsonreuters.com;;))